http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=6845931&dopt=Books

 

NCBI

PubMed

PubMed

Nucleotide

Protein

Genome

Structure

PopSet

Taxonomy

OMIM

 Search for

 

Limits

Preview/Index

History

Clipboard

 

 

 

About Entrez
spacer gif

back to About Entrez

back to About Entrez


Entrez PubMed
Overview
Help | FAQ
Tutorial
New/Noteworthy

PubMed Services
Journal Browser
MeSH Browser
Single Citation Matcher
Batch Citation Matcher
Clinical Queries
Cubby

Related Resources
Order Documents
Grateful Med
Consumer Health
Clinical Alerts
ClinicalTrials.gov


Privacy Policy

 

 

 

 

   

 

 

1: Zh Mikrobiol Epidemiol Immunobiol 1983 Mar;(3):87-92

Related Articles


[Evaluation of the toxic action of prophylactic and therapeutic preparations on cell cultures. III. The detection of toxic properties in medical biological preparations by the degree of cell damage in the L132 continuous cell line].

[Article in Russian]

Kravchenko AT, Dzagurov SG, Chervonskaia GP.

The methods of the quality control of medical biological preparations, including tests on animals, do not ensure the complete absence of toxicity in a final product. The use of the method of "subcultures with the introduced preparation" makes it possible to determine the toxicity of both specific and nonspecific components of vaccines and sera from the number of dead and damaged cells. The toxic action of preparations kills and damages the cells at the site of injection, thus inducing the formation of autoantigens whose effect on the body cannot be predicted. Thus thimerosal, commonly used as preservative, has been found not only to render its primary toxic effect, but also capable of changing the properties of cells. This fact suggests that the use of thimerosal for the preservation of medical biological preparations, especially those intended for children, is inadmissible.

MeSH Terms:

·         Allergens/toxicity

·         Animal

·         Bacterial Vaccines/toxicity

·         Biological Products/toxicity*

·         Cell Line

·         Cells, Cultured

·         Immunoglobulins/toxicity

·         L Cells (Cell Line)/drug effects*

·         Methods

·         Mice

·         Quality Control

·         Thimerosal/toxicity

·         Viral Vaccines/toxicity


Substances:

·         Thimerosal

·         Viral Vaccines

·         Immunoglobulins

·         Biological Products

·         Bacterial Vaccines

·         Allergens


PMID: 6845931 [PubMed - indexed for MEDLINE]


 

 

 

 

   

 

 

 

 

 

 

 

 

 Write to the Help Desk
NCBI | NLM | NIH
Department of Health & Human Services
Freedom of Information Act | Disclaimer

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.